Plain-English translation of NCT05231135 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a registry study—a large database—that collects information about people living with HIV who have been diagnosed with lymphoma (a blood cancer). Researchers are gathering data about how these patients are treated and what happens to them over time, so doctors can better understand which treatments work best and how to improve care.
Lymphoma in people with HIV is uncommon but serious, and treatment approaches can vary widely. By collecting real-world information about many patients' experiences and outcomes, doctors hope to identify the most effective treatment strategies and improve survival for future patients.
You likely qualify if…
You likely don't qualify if…
If you join, your doctors will share your medical records and treatment information with the registry—including your diagnosis details, the treatment you receive (which follows standard medical guidelines), and how you respond to treatment over time. Your information will be kept private and identified only by a code number. You will continue receiving your regular cancer and HIV care as normal; this study simply tracks and collects that information to help researchers learn from your experience.
AI-generated summary from trial data · Jun 23, 2026 · Not medical advice
Germany
Netherlands
Spain
Sponsor
Rotkreuzklinikum München gGmbH
Enrollment target
~300 participants
Started
August 2021
Primary completion
August 2024
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in April 2023.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Marcus Hentrich, MD
Rotkreuzklinikum München
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.